BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34071241)

  • 1. Anacardic Acids from
    Galot-Linaldi J; Hernández-Sánchez KM; Estrada-Muñiz E; Vega L
    Molecules; 2021 May; 26(11):. PubMed ID: 34071241
    [No Abstract]   [Full Text] [Related]  

  • 2. Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model.
    Gnanaprakasam JNR; López-Bañuelos L; Vega L
    Toxicol Appl Pharmacol; 2021 Jan; 410():115359. PubMed ID: 33290779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antineoplastic agent anacardic 6-pentadecyl salicylic acid produces immunomodulation in vivo via the activation of MAPKs.
    Gnanaprakasam JNR; Estrada-Muñiz E; Vega L
    Toxicol Appl Pharmacol; 2019 Aug; 376():82-92. PubMed ID: 31129177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound healing activity of the hydroalcoholic extract and the main metabolites of Amphipterygium adstringens (cuachalalate) in a rat excision model.
    Pérez-Contreras CV; Alvarado-Flores J; Orona-Ortiz A; Balderas-López JL; Salgado RM; Zacaula-Juárez N; Krötzsch E; Navarrete A
    J Ethnopharmacol; 2022 Jul; 293():115313. PubMed ID: 35461988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anacardic 6-pentadecyl salicylic acid induces macrophage activation via the phosphorylation of ERK1/2, JNK, P38 kinases and NF-κB.
    Gnanaprakasam JNR; Estrada-Muñiz E; Vega L
    Int Immunopharmacol; 2015 Dec; 29(2):808-817. PubMed ID: 26371858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxic and cytostatic effects of 6-pentadecyl salicylic anacardic acid in transformed cell lines and peripheral blood mononuclear cells.
    Alam-Escamilla D; Estrada-Muñiz E; Solís-Villegas E; Elizondo G; Vega L
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Jan; 777():43-53. PubMed ID: 25726174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphypterygium adstringens anacardic acid mixture inhibits quorum sensing-controlled virulence factors of Chromobacterium violaceum and Pseudomonas aeruginosa.
    Castillo-Juárez I; García-Contreras R; Velázquez-Guadarrama N; Soto-Hernández M; Martínez-Vázquez M
    Arch Med Res; 2013 Oct; 44(7):488-94. PubMed ID: 24126126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Helicobacter pylori activity of anacardic acids from Amphipterygium adstringens.
    Castillo-Juárez I; Rivero-Cruz F; Celis H; Romero I
    J Ethnopharmacol; 2007 Oct; 114(1):72-7. PubMed ID: 17768020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anacardic acid induces cell apoptosis associated with induction of ATF4-dependent endoplasmic reticulum stress.
    Huang H; Hua X; Liu N; Li X; Liu S; Chen X; Zhao C; Lan X; Yang C; Dou QP; Liu J
    Toxicol Lett; 2014 Aug; 228(3):170-8. PubMed ID: 24853302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of the new anacardic acid 6-[16'Z-nonadecenyl]-salicylic acid and evaluation of its antimicrobial activity against Streptococcus mutans and Porphyromonas gingivalis.
    Rivero-Cruz BE; Esturau N; Sánchez-Nieto S; Romero I; Castillo-Juárez I; Rivero-Cruz JF
    Nat Prod Res; 2011 Aug; 25(13):1282-7. PubMed ID: 21815722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway.
    Park M; Upton D; Blackmon M; Dixon V; Craver S; Neal D; Perkins D
    BMC Complement Altern Med; 2018 Feb; 18(1):71. PubMed ID: 29463243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin delays mammary cancer 4T1 growth in mice.
    Souza CM; Gamba Cde O; Campos CB; Lopes MT; Ferreira MA; Andrade SP; Cassali GD
    Pathol Res Pract; 2013 Jan; 209(1):24-9. PubMed ID: 23164716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
    Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
    J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
    Hiraga T; Ueda A; Tamura D; Hata K; Ikeda F; Williams PJ; Yoneda T
    Int J Cancer; 2003 Oct; 106(6):973-9. PubMed ID: 12918079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model.
    de Souza CM; Araújo e Silva AC; de Jesus Ferraciolli C; Moreira GV; Campos LC; dos Reis DC; Lopes MT; Ferreira MA; Andrade SP; Cassali GD
    Biomed Pharmacother; 2014 Feb; 68(1):51-7. PubMed ID: 24054045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
    Fujimoto S
    Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
    Ghosh S; Pal A; Ray M
    Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2.
    Upadhyay AK; Singh S; Chhipa RR; Vijayakumar MV; Ajay AK; Bhat MK
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):177-85. PubMed ID: 16806341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin.
    Fournier C; Hecquet B; Bastian G; Khayat D
    Cancer Chemother Pharmacol; 1992; 29(6):461-6. PubMed ID: 1568289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
    Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
    J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.